Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Early Phase 1
2(50.0%)
N/A
1(25.0%)
Phase 1
1(25.0%)
4Total
Early Phase 1(2)
N/A(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT07277959Completed

Marsupialization of Odontogenic Cysts

Role: lead

NCT07138625Not ApplicableNot Yet Recruiting

Nebulized 3% Hypertonic Saline Versus Normal Saline in Managing Children With Acute Bronchiolitis: A Randomized Controlled Trial

Role: lead

NCT06960278Early Phase 1Completed

Effect of Alum Stone Containing Mucosal Adhesive Patches on Healing of Recurrent Aphthous Stomatitis

Role: lead

NCT06639711Phase 1Active Not Recruiting

Taurine Eye Drops May Prevent the Progression of Cataract

Role: lead

NCT04569825Early Phase 1Unknown

Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease

Role: lead

All 5 trials loaded